Lung cancer is the leading cause of cancer-related mortality in the United States and is comprised of two main histologic subtypes: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Fortunately, advanced drug therapies and genetic testing are making a big difference for many patients and their families.
Hear from highly-regarded lung cancer experts, nurse practitioners and patients from across the globe by viewing our interviews.
Upcoming EventsSee all events
Wednesday, April 8, 2020
Join experts Dr. Sandip Patel (UCSD) and Dr. Thomas Marron (Mount Sinai, NY) as they discuss clinical trials for lung cancer patients and what impact the coronavirus may have on these important research programs. Please send questions in advance to [email protected] info